Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden
· Delayed Price · Currency is SEK 458.50
-5.00 (-1.08%)
Feb 21, 2025, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 14.44 billion as of February 21, 2025. Its market cap has increased by 72.05% in one year.
Market Cap
14.44B
Enterprise Value
14.06B
Revenue
822.42M
Ranking
n/a
PE Ratio
84.28
Stock Price
458.50
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 14.44B, an increase of 3,785.61%. That is a compound annual growth rate of 34.39%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 108.46B |
| Getinge AB | 58.89B |
| Sectra AB | 47.92B |
| Camurus AB | 38.53B |
| Medicover AB | 30.55B |
| Vitrolife AB | 28.89B |
| Elekta AB | 25.22B |
| Vimian Group AB | 23.47B |